Plain-English translation of NCT06162403 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing peripheral nerve stimulation (PNS)—a device that delivers gentle electrical pulses to affected nerves—to help reduce pain caused by chemotherapy-related nerve damage in the feet and legs. Researchers want to see if this treatment can help people feel better and move more easily, and whether it improves the actual health of the nerve fibers themselves.
Nerve pain from chemotherapy can be long-lasting and difficult to treat with standard pain medications alone. This trial exists to explore whether electrical stimulation might offer relief for people still struggling with this pain after finishing cancer treatment.
You likely qualify if…
You likely don't qualify if…
You would have thin electrical leads placed under your skin using a needle, targeting the nerves causing your pain. The device delivers mild electrical pulses 24 hours a day for up to 60 days. During this time and afterward, you'll come to study visits where researchers will test your pain levels, examine how well you can walk, and check the health of your nerve fibers to see if the treatment is helping.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Sponsor
M.D. Anderson Cancer Center
Enrollment target
~10 participants
Started
February 2024
Primary completion
December 2027
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Saba Javed, MD
M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.